My Profile
Policy
On behalf of our members, AdvaMed® works on countless fronts to ensure patients have timely access to life-changing technologies. Find out more about our top policy issues.
AdvaMed® Advancements: Q3 2025 Report. Amid an increasingly charged political environment, AdvaMed remained a steady, persuasive voice for medtech innovation. From mobilizing rapid action on the Section 232 investigation to…
AdvaMed® periodically compiles benchmarking data on Member companies’ policies regarding the provision of meals and refreshments to U.S. Health Care Professionals to assist companies in understanding industry trends and practices…
Explore AdvaMed’s 2024 Economic Impact Report, developed by Frost & Sullivan, highlighting medtech’s vital contributions to the U.S. economy
Achieve the highest levels of compliance with principles on consulting arrangements, training, education and other forms of communications.
Member-only overview of IEEPA reciprocal & “fentanyl” tariffs under EO 14257, summarizing key federal court challenges and rulings through August 15, 2025.
AdvaMed® periodically compiles benchmarking data on Member companies’ compliance policies regarding travel and lodging for U.S. Health Care Professionals to assist companies in understanding industry trends and practices when the…
AdvaMed® Advancements: Q3 2025 Report. Amid an increasingly charged political environment, AdvaMed remained a steady, persuasive voice for medtech innovation. From mobilizing rapid action on the Section 232 investigation to…
AdvaMed® periodically compiles benchmarking data on Member companies’ policies regarding the provision of meals and refreshments to U.S. Health Care Professionals to assist companies in understanding industry trends and practices…
Explore AdvaMed’s 2024 Economic Impact Report, developed by Frost & Sullivan, highlighting medtech’s vital contributions to the U.S. economy
Achieve the highest levels of compliance with principles on consulting arrangements, training, education and other forms of communications.
AdvaMed® members have access to our full library of industry resources.
As patient advocates, we’ve witnessed countless stories of hope deferred and lives put on hold while Medicare beneficiaries wait several years for access to breakthrough medical technologies that the FDA…
WASHINGTON—AdvaMed, the world’s largest trade association representing medtech innovators, today welcomed a letter from U.S. Senators Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.), co-chairs of the Senate Diabetes Caucus, and…
WASHINGTON—AdvaMed, the medtech association, called the U.S.-China trade announcement a positive step toward supporting the U.S.-led medtech industry and its service to patients nationwide and globally.
WASHINGTON—AdvaMed, the medtech association, today submitted formal comments responding to the U.S. Department of Commerce investigation into whether the U.S.’s current level of medtech imports has national security implications. The…
San Diego—AdvaMed, the Medtech Association, the world’s largest trade association representing medtech innovators, just concluded its most impactful MedTech Conference to date, welcoming 3,708 attendees and representatives from 1,800 companies…
WASHINGTON, D.C. – AdvaMed, the Medtech Association, today announced that its board of directors has unanimously approved revisions to the AdvaMed Code of Ethics on Interactions with Health Care Professionals.
WASHINGTON, D.C. – AdvaMed, the Medtech Association, recently published a technical performance and safety bulletin titled, “Remote Device Operations: Common Challenges and Mitigation Strategies” to help health care providers, device…
WASHINGTON—AdvaMed, the MedTech Association, released the following statement from President and CEO Scott Whitaker on the Administration’s announcement of its investigation under Section 232 of the Trade Expansion Act into…
WASHINGTON—AdvaMed, the medtech association, today thanked the U.S. House Energy and Commerce Health Subcommittee for highlighting the need for Medicare coverage of FDA-authorized breakthrough medtech and releasing a discussion draft…
AdvaMed was honored to address delegates at the 12th Asia-Pacific Economic Cooperation (APEC) Business Ethics for SMEs Forum held in Seoul, Korea, on September 8-9, 2025. AdvaMed galvanized delegates from…
We are pleased to provide AdvaMed® members with the Membership Newsletter, a monthly publication designed to communicate relevant news, resources, events and policy updates.